Table of Contents
Summary GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth” that provides key data, information and analysis of the major trends and issues affecting the biosimilar market in developed countries covering the US, the top five European markets and J...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
00 1 718 213 49 04
PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013 Summary GlobalData's "PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013" report, provides ...
Introduction What are the implications for regulators, biosimilar companies and branded manufacturers? There are few areas of the pharmaceutical market more hotly debated than biosimilars yet the pathway ...
This report is an in-depth financial evaluation of the Global Generic Pharmaceuticals. Using the unique Plimsoll method of analysis, each of the largest 198 companies is individually assessed and ranked ...
... Hale & tempest how to provide affordable medicines in today S competitive global market dr. Brian w tempest www.Briantempest.Com world generic medicines congress london ...
Reportlinker.com © Copyright 2013. All rights reserved.